Clinical Trial Update: Safety of Discontinuing NSBBs in Cirrhotic Patients With Managed Primary Aetiological Factors

View source ↗

Summary

A registered clinical trial from The Chinese University of Hong Kong is evaluating the safety of discontinuing non-selective beta-blockers in cirrhotic patients…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis
• Esophageal Varices
• Portal Hypertension

Drugs mentioned

• Non-selective beta-blockers

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Portal Hypertension, Cirrhosis | Status: RECRUITING